Unlocking the secrets of cerebral malaria using extracellular vesicles

Cerebral malaria is a severe and potentially deadly form of malaria that affects the brain, leading to serious complications or even death. Studying how this disease impacts the brain is challenging, especially since researchers can’t easily access brain tissue in living patients. However, a new study by researchers at the KEMRI-Wellcome Trust Research Programme offers a promising way to understand these effects without invasive procedures.

What Are Extracellular Vesicles?

Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream. These vesicles carry important biological molecules, including RNA, which is a type of genetic material that helps cells function. Because EVs can reflect what’s happening inside the body, scientists are increasingly using them to study diseases.

The Study: Using EVs to Understand Cerebral Malaria

In this study, the researchers collected blood samples from patients with cerebral malaria and healthy individuals from the same community. They isolated the EVs from the blood plasma and analyzed the RNA content inside these vesicles. By examining the RNA, they could identify which types of brain cells the RNA came from and how these cells were reacting to the disease.

Key Findings

1. Brain-Origin RNA in EVs: The researchers found that EVs from patients with cerebral malaria contained RNA that originated from the brain. This discovery means that EVs can provide a noninvasive way to study how cerebral malaria affects brain tissue.
2. Disease Progression: By analyzing the RNA profiles in the EVs, the researchers could trace the progression of the disease. They noticed that as the disease worsened, the amount of RNA from neurons (brain cells responsible for transmitting signals) decreased. In contrast, RNA from other brain cells, such as glial cells (which support neurons) and endothelial cells (which line blood vessels), increased. This shift in RNA content correlated with more severe disease symptoms.
3. Molecular Pathways Involved: The study also identified specific molecular pathways that were more active as the disease progressed. For example, they observed increased activity in pathways related to VEGFA-VEGFR signaling, which is involved in blood vessel growth, and glutamatergic signaling, which is related to neurotransmitter function. They also found signs of increased activation in platelets and neutrophils, which are types of blood cells involved in inflammation and immune responses.

The solid tissue atlas of circulating EV-RNA in cerebral malaria

(A) The relative comparison of blood and solid tissue RNA fractions in plasma EVs from patients with cerebral malaria. (B) The relative distributions of solid tissue fractions of circulating EV-RNA in cerebral malaria. (C) The estimated absolute proportion of RNA expressed by the brain and nerves is higher in retinopathy-positive (CM-R⁺) and negative (CM-R⁻) cerebral malaria compared to community controls (CC). (D) Brain cell relative fractions estimated from the plasma EV-RNA data. (E) Heatmap clustering of differentially enriched genes between patients with CM-R⁺ and CM-R⁻. (F) Top terms associated with genes significantly increased (red) and decreased (blue) in CM-R⁺. The top terms in the blood and brain domains are shown.

This research suggests that EVs circulating in the blood can be used as a window into the brain, providing valuable insights into how cerebral malaria affects brain tissue. Since EVs can be collected from a simple blood sample, this approach could make it easier to study and monitor cerebral malaria in patients, potentially leading to better treatments and outcomes.

This study highlights a novel, noninvasive method for exploring the impact of cerebral malaria on the brain, offering hope for new ways to understand and combat this devastating disease.